Characterisation of bladder cancer drug responses in organoids and ex vivo models

by M. Kiener, S. Karkampouna, F. La Manna, M. De Menna, G.N. Thalmann, R. Seiler-Blarer, M. Kruithof-De Julio
Published 2020-07-01

Germline mutations in patients with muscle-invasive bladder cancer reveal potential requirements for cancer development

by F.A. Krentel, F. Singer, R.G. Lourdes, M. De Menna, N. Giudici, D. Stekhoven, M. Kruithof-De Julio, R. Seiler-Blarer
Published 2020-07-01

Molecular signatures of bone metastatic breast and prostate cancer

by F. La Manna, M. De Menna, E. Rodrigues Sousa, M. De Filippo, P. Kloen, L. Beimers, G.N. Thalmann, M. Kruithof-De Julio
Published 2020-07-01

Personalised organoid drug treatment and therapy resistance characterization based on novel BRCA2 prostate cancer xenograft of SPOP-like phenotype and microsatellite instability

by S. Karkampouna, F. La Manna, M.R. De Filippo, M. De Menna, E. Zoni, J. Grosjean, I. Klima, A. Garofoli, V. Genitsch, D. Keller, T.H. Booij, C.U. Stirnimann, A. Sboner, C.K.Y. Ng, S. Piscuoglio, M. Spahn, A.R. Mark, G.N. Thalmann, M. Kruithof-De Julio
Published 2020-07-01